194 related articles for article (PubMed ID: 26069720)
1. Recent progress in the genetics of diabetic microvascular complications.
Chang YC; Chang EY; Chuang LM
World J Diabetes; 2015 Jun; 6(5):715-25. PubMed ID: 26069720
[TBL] [Abstract][Full Text] [Related]
2. Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies.
Kwak SH; Park KS
Endocrinol Metab (Seoul); 2015 Jun; 30(2):147-58. PubMed ID: 26194074
[TBL] [Abstract][Full Text] [Related]
3. Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy.
Davoudi S; Sobrin L
Rev Diabet Stud; 2015; 12(3-4):243-59. PubMed ID: 26859656
[TBL] [Abstract][Full Text] [Related]
4. Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study.
Yoshioka K
Diabetes Ther; 2018 Feb; 9(1):75-85. PubMed ID: 29177923
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).
Iyengar SK; Abboud HE; Goddard KA; Saad MF; Adler SG; Arar NH; Bowden DW; Duggirala R; Elston RC; Hanson RL; Ipp E; Kao WH; Kimmel PL; Klag MJ; Knowler WC; Meoni LA; Nelson RG; Nicholas SB; Pahl MV; Parekh RS; Quade SR; Rich SS; Rotter JI; Scavini M; Schelling JR; Sedor JR; Sehgal AR; Shah VO; Smith MW; Taylor KD; Winkler CA; Zager PG; Freedman BI;
Diabetes; 2007 Jun; 56(6):1577-85. PubMed ID: 17363742
[TBL] [Abstract][Full Text] [Related]
6. A study of diabetes complications in an endogamous population: an emerging public health burden.
Bener A; Al-Laftah F; Al-Hamaq AO; Daghash M; Abdullatef WK
Diabetes Metab Syndr; 2014; 8(2):108-14. PubMed ID: 24907176
[TBL] [Abstract][Full Text] [Related]
7. Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia.
Iyengar SK; Freedman BI; Sedor JR
Semin Nephrol; 2007 Mar; 27(2):208-22. PubMed ID: 17418689
[TBL] [Abstract][Full Text] [Related]
8. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
Obrosova IG; Julius UA
Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).
Raman R; Gupta A; Krishna S; Kulothungan V; Sharma T
J Diabetes Complications; 2012; 26(2):123-8. PubMed ID: 22446033
[TBL] [Abstract][Full Text] [Related]
10. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.
Imperatore G; Hanson RL; Pettitt DJ; Kobes S; Bennett PH; Knowler WC
Diabetes; 1998 May; 47(5):821-30. PubMed ID: 9588456
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell distribution width and diabetes-associated complications.
Magri CJ; Fava S
Diabetes Metab Syndr; 2014; 8(1):13-7. PubMed ID: 24661752
[TBL] [Abstract][Full Text] [Related]
12. Diabetic microvascular complications: can patients at risk be identified? A review.
Girach A; Manner D; Porta M
Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of associations between single nucleotide polymorphisms in the FRMD3 and CARS genes and diabetic nephropathy in a Kuwaiti population.
Al-waheeb S; Alwohhaib M; Abdelghani A; Al-Sharrah S; Al-Shafey E; Al-Sahow A; Alyatama N; Dashti AA; Hussain N
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909942
[TBL] [Abstract][Full Text] [Related]
14. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
Babaliche P; Nadpara RA; Maldar A
J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.
Arora MK; Singh UK
Vascul Pharmacol; 2013 Apr; 58(4):259-71. PubMed ID: 23313806
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications.
Demaine AG
Curr Med Chem; 2003 Aug; 10(15):1389-98. PubMed ID: 12871136
[TBL] [Abstract][Full Text] [Related]
17. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Coccheri S
Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
[TBL] [Abstract][Full Text] [Related]
18. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes.
Afarideh M; Aryan Z; Ghajar A; Ganji M; Ghaemi F; Saadat M; Heidari B; Mechanick JI; Esteghamati A
Prim Care Diabetes; 2019 Dec; 13(6):505-514. PubMed ID: 31054837
[TBL] [Abstract][Full Text] [Related]
19. Genetics of diabetic nephropathy in diverse ethnic groups.
Brorsson C; Pociot F
Contrib Nephrol; 2011; 170():8-18. PubMed ID: 21659753
[TBL] [Abstract][Full Text] [Related]
20. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
